Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) Assets Average (2021 - 2025)

Historic Assets Average for SOPHiA GENETICS (SOPH) over the last 5 years, with Q3 2025 value amounting to $170.5 million.

  • SOPHiA GENETICS's Assets Average fell 491.38% to $170.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $170.5 million, marking a year-over-year decrease of 491.38%. This contributed to the annual value of $180.7 million for FY2024, which is 1967.34% down from last year.
  • Latest data reveals that SOPHiA GENETICS reported Assets Average of $170.5 million as of Q3 2025, which was down 491.38% from $162.2 million recorded in Q2 2025.
  • In the past 5 years, SOPHiA GENETICS's Assets Average registered a high of $327.5 million during Q4 2021, and its lowest value of $151.0 million during Q1 2025.
  • Over the past 5 years, SOPHiA GENETICS's median Assets Average value was $214.5 million (recorded in 2023), while the average stood at $220.2 million.
  • Over the last 5 years, SOPHiA GENETICS's Assets Average had its largest YoY gain of 2024.08% in 2022, and its largest YoY loss of 2452.59% in 2022.
  • Over the past 5 years, SOPHiA GENETICS's Assets Average (Quarter) stood at $327.5 million in 2021, then fell by 24.53% to $247.2 million in 2022, then decreased by 16.67% to $206.0 million in 2023, then fell by 19.2% to $166.5 million in 2024, then grew by 2.45% to $170.5 million in 2025.
  • Its last three reported values are $170.5 million in Q3 2025, $162.2 million for Q2 2025, and $151.0 million during Q1 2025.